Quadruple therapy for Helicobacter pylori infection - Authors' reply

Comment

Jyh-Ming Liou et al. Lancet. 2013.

. 2013 Apr 27;381(9876):1459-60.

doi: 10.1016/S0140-6736(13)60926-5.

No abstract available

Comment on

Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial.
Liou JM, Chen CC, Chen MJ, Chen CC, Chang CY, Fang YJ, Lee JY, Hsu SJ, Luo JC, Chang WH, Hsu YC, Tseng CH, Tseng PH, Wang HP, Yang UC, Shun CT, Lin JT, Lee YC, Wu MS; Taiwan Helicobacter Consortium. Liou JM, et al. Lancet. 2013 Jan 19;381(9862):205-13. doi: 10.1016/S0140-6736(12)61579-7. Epub 2012 Nov 16. Lancet. 2013. PMID: 23158886 Clinical Trial.
Quadruple therapy for Helicobacter pylori infection.
Molina-Infante J, Gisbert JP. Molina-Infante J, et al. Lancet. 2013 Apr 27;381(9876):1459. doi: 10.1016/S0140-6736(13)60925-3. Lancet. 2013. PMID: 23622281 No abstract available.